| Common Stock, Shares Authorized |
290,000,000 |
shares |
0% |
Q2 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
93,300 |
shares |
-100% |
Q2 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
| Deferred Tax Assets, Valuation Allowance |
$59,535 |
USD |
21% |
Q2 2024 |
Q3 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$170,101 |
USD |
21% |
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q2 2024 |
Q3 2024 |
| Additional Paid in Capital |
$74,685 |
USD |
43% |
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
| Current Federal Tax Expense (Benefit) |
$34,889 |
USD |
26% |
Q1 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |